1. Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer
   Tetsuro Yoshimaru et al, 2015, Cancer Sci CrossRef
2. Challenges of Endocrine Therapy in Breast Cancer
   Sepideh Mansouri et al, 2017 CrossRef
3. Omega-3 free fatty acids inhibit tamoxifen-induced cell apoptosis
   Shufan Wu et al, 2015, Biochemical and Biophysical Research Communications CrossRef
4. The Impact of Anti-tumor Agents on ER-Positive MCF-7 and HER2-Positive SKBR-3 Breast Cancer Cells Biomechanics
   Despoina N. Metsiou et al, 2019, Ann Biomed Eng CrossRef
5. Combination of low-concentration of novel phytoestrogen (8,9)-furanyl-pterocarpan-3-ol from Pachyrhizus erosus attenuated tamoxifen-associated growth inhibition on breast cancer T47D cells
   Arief Nurrochmad et al, 2013, Asian Pacific Journal of Tropical Biomedicine CrossRef
6. Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects
   Yoko Omoto et al, 2015, Cancer Sci CrossRef
7. The role of sex hormones and steroid receptors on female reproductive cancers.
   Luiz Gustavo de Almeida Chuffa et al, 2017, Steroids CrossRef
8. GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer
   Luis Molina et al, 2017, Expert Opinion on Therapeutic Targets CrossRef
9. Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1/2 signals
   Jingtao Zhong et al, 2018, Int J Mol Med CrossRef
10. Co-culture hydrogel micro-chamber array-based plate for anti-tumor drug development at single-element resolution
    Yana Shafran et al, 2020, Toxicology in Vitro CrossRef
11. Cytokine and inflammatory mediators are associated with cytotoxic, anti-inflammatory and apoptotic activity of honeybee venom
    Mohamed A. Salama et al, 2020 CrossRef
12. High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study
    Yanhong Su et al, 2021, Ther Adv Med Oncol CrossRef
13. Reduced IQGAP2 expression promotes EMT and inhibits apoptosis by modulating the MEK-ERK and p38 signaling in breast cancer irrespective of ER status
    Dinesh Kumar et al, 2021, Cell Death Dis CrossRef
14. Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer
    John J. Kim et al, 2021, PLoS ONE CrossRef
15. GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells
    Yue Zhang et al, 2022, Oncogene CrossRef
16. Tamoxifen resistance induction results in the upregulation of ABCG2 expression and mitoxantrone resistance in MCF-7 breast cancer cells
    Asefeh Dahmardeh Ghalehno et al, 2023, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
17. Microbial Therapy and Breast Cancer Management: Exploring Mechanisms, Clinical Efficacy, and Integration within the One Health Approach
    Charalampos Filippou et al, 2024, IJMS CrossRef
18. The activation of the G-protein-coupled estrogen receptor promotes the aggressiveness of MDA-MB231 cells by targeting the IRE1α/TXNIP pathway
    Maryam Mohammad-Sadeghipour et al, 2024 CrossRef